Literature DB >> 8271063

Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.

W T Leung1, W Y Lau, S K Ho, M Chan, N W Leung, J Lin, C Metreweli, P J Johnson, A K Li.   

Abstract

UNLABELLED: With increased use of intraarterial administration of chemotherapeutic and radioactive particulate agents, it is necessary to assess agent delivery in the lung.
METHODS: Technetium-99m-labeled macroaggregated albumin (99mTc-MAA) delivered through the hepatic artery was used to determine the degree of lung shunting in 125 patients with hepatocellular carcinoma (HCC).
RESULTS: The percentage of lung shunting varied among patients and it ranged from less than 1% to 67.2%, with a median of 8.1%. The degree of shunting depended on the vascularity of the tumors but not on the tumor size. The effect of angiotensin II on lung shunting was tested on six patients and there was no significant difference found between those patients who were pre-treated with angiotensin II and those who were not. One patient who underwent a liver resection, had a significant decrease in lung shunting from 28.5% to less than 1% after surgery.
CONCLUSION: The lack of effect of angiotensin II together with the almost complete ablation of lung shunting by tumor resection suggested neoplastic blood vessels were responsible for the shunting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8271063

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.

Authors:  Francesco Giammarile; Lisa Bodei; Carlo Chiesa; Glenn Flux; Flavio Forrer; Françoise Kraeber-Bodere; Boudewijn Brans; Bieke Lambert; Mark Konijnenberg; Françoise Borson-Chazot; Jan Tennvall; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07       Impact factor: 9.236

2.  Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription.

Authors:  Chi Lai Ho; Sirong Chen; Shing Kee Cheung; Yim Lung Leung; Kam Chau Cheng; Ka Nin Wong; Yuet Hung Wong; Thomas Wai Tong Leung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-11       Impact factor: 9.236

3.  Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.

Authors:  R S Stubbs; R J Cannan; A W Mitchell
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

4.  Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

Authors:  S Ho; W Y Lau; T W Leung; M Chan; Y K Ngar; P J Johnson; A K Li
Journal:  Eur J Nucl Med       Date:  1996-08

5.  Diagnostic angioscintigraphic evaluation of malignant hepatic tumors before catheter embolization: determination of shunt, flow distribution, and reflux.

Authors:  R H Walser; A R Haldemann; H Rösler; P Koranda; J A Kinser; J Triller
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Mar-Apr       Impact factor: 2.740

Review 6.  Tumor thrombus: incidence, imaging, prognosis and treatment.

Authors:  Keith Bertram Quencer; Tamir Friedman; Rahul Sheth; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

7.  Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization.

Authors:  Kazim H Narsinh; Mark Van Buskirk; Andrew S Kennedy; Mohammed Suhail; Naif Alsaikhan; Carl K Hoh; Kenneth Thurston; Jeet Minocha; David S Ball; Steven J Cohen; Michael Cohn; Douglas M Coldwell; Alain Drooz; Eduardo Ehrenwald; Samir Kanani; Charles W Nutting; Fred M Moeslein; Michael A Savin; Sabine Schirm; Samuel G Putnam; Navesh K Sharma; Eric A Wang; Steven C Rose
Journal:  Radiology       Date:  2016-07-19       Impact factor: 11.105

8.  Salvage surgery following downstaging of unresectable hepatocellular carcinoma.

Authors:  Wan-yee Lau; Stephen K W Ho; Simon C H Yu; Eric C H Lai; Choong-tsek Liew; Thomas W T Leung
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.

Authors:  Young Chul Kim; Yun Hwan Kim; Soon Ho Um; Yeon Seok Seo; Eun Kyung Park; Sun Young Oh; You Mie Han; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2010-11-24

10.  Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.

Authors:  M A D Vente; T C de Wit; M A A J van den Bosch; W Bult; P R Seevinck; B A Zonnenberg; H W A M de Jong; G C Krijger; C J G Bakker; A D van het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.